Login / Signup

Minimum Alveolar Concentration-Awake of Sevoflurane is Decreased in Patients with Parkinson's Disease: An Up-and-Down Sequential Allocation Trial.

Chengwei YangFang KangWenjun MengMeirong DongXiang HuangSheng WangZhiyi ZuoJuan Li
Published in: Clinical interventions in aging (2021)
Registered at ChiCTR1900026956.
Keyphrases
  • study protocol
  • phase iii
  • clinical trial
  • phase ii
  • deep brain stimulation
  • randomized controlled trial
  • open label